Inflammatory myofibroblastic tumors of the central nervous system that express anaplastic lymphoma kinase have a high recurrence rate
- PMID: 23776756
- PMCID: PMC3683168
- DOI: 10.4103/2152-7806.112614
Inflammatory myofibroblastic tumors of the central nervous system that express anaplastic lymphoma kinase have a high recurrence rate
Abstract
Background: Inflammatory myofibroblastic tumors (IMTs) of the central nervous system (CNS) are rare entities with diverse histopathological features and varying propensities to recur.
Case description: A 26 year-old male with an IMT of the CNS of the left tentorium had tumor progression 2 months after partial surgical resection. Histopathological studies confirmed expression of ALK. Macroscopic total resection was performed followed by radiotherapy. A recurrence occurred 20 months after the second surgery that necessitate reoperation. Including the present case, we identified 30 cases of IMT of the CNS corresponding to our search criteria in the literature. The extent of resection was reported in 26 of these cases. Gross total resection was done in 75% of ALK-positive and in 61% of ALK-negative cases. Recurrence rate after gross total resection for ALK-positive and ALK-negative cases was 33% and 9%, respectively. Every recurrence in ALK-positive patients occurred within 2 years after surgery.
Conclusion: IMT of the CNS are a heterogeneous group of tumors and the treatment of choice is complete surgical resection. Because of the high recurrence rate reported for IMT of the CNS expressing ALK, a closed follow-up is recommended. When faced with an early recurrence, a surgical resection followed by radiotherapy may be advised.
Keywords: Anaplastic lymphoma kinase; fibrohistiocytic; inflammatory myofibroblastic tumor; plasma cell granuloma; pseudotumor; recurrence.
Figures






References
-
- Buccoliero AM, Caldarella A, Santucci M, Ammannati F, Mennonna P, Taddei A, et al. Plasma cell granuloma – an enigmatic lesion: Description of an extensive intracranial case and review of the literature. Arch Pathol Lab Med. 2003;127:e220–3. - PubMed
-
- Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569–76. - PubMed
-
- de Oliveira RS, Amato MC, Brassesco MS, Valera ET, Juca CE, Neder L, et al. Clinical and cytogenetic analysis of an intracranial inflammatory myofibroblastic tumor induced by a ventriculoperitoneal shunt. J Neurosurg Pediatr. 2009;4:372–7. - PubMed
-
- Fletcher CDM, Unni KK, Mertens F World Health Organization. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. International Agency for Research on Cancer.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources